The European Forum for GCP (EFGCP) has moved its annual two-day conference from the traditional slot in late January to the beginning of March.
Under the title of “Bringing together the two worlds of medicine & device research to better serve public, patients & research participants,” EFGCP Annual Conference 2016 will take place on March 1 and 2, in Brussels, Belgium.
The aim of the event is to help the two worlds of pharma and medical devices develop research, medicines and equipment for patient benefit.
“The EU Medical Device regulations are almost upon us. These will have significant consequences, similar to the Clinical Trail Regulations and there is an opportunity to learn from pharma experience,” noted EFGCP in a statement issued October 1.
The meeting will outline what regulations will mean to the devices industry and focus on the lessons learnt from experience with the clinical trial regulations. The tangible outcomes will be an EFGCP report and recommendations that will be provided to those involved in the legislative process.
For 22 years the European Forum for Good Clinical Practice has acted as a forum to bring patients, researchers, sponsors, competent authorities and ethics committees together and debate current topics. It is recognized as an important forum for multi-stakeholder debate.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.